LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples